EN | RU
EN | RU

Help Support

Back

Association between NAFLD and Plasminogen Activator Inhibitor-1 levels

NAFLD NAFLD
NAFLD NAFLD

The purpose of a systematic review and meta-analysis was to better understand the role of Plasminogen Activator Inhibitor-1 (PAI-1) in non-alcoholic fatty liver disease (NAFLD).

See All

Key take away

Adult NAFLD (biopsy-proven and computed tomography-diagnosed) is related to higher serum Plasminogen Activator Inhibitor-1 levels.

Background

The purpose of a systematic review and meta-analysis was to better understand the role of Plasminogen Activator Inhibitor-1 (PAI-1) in non-alcoholic fatty liver disease (NAFLD).

Method

With the aid of a predefined search string, a thorough search of EMBASE, PubMed, and Cochrane Library was carried out. The NHLBI quality assessment methods were used to examine the studies' quality. Mean difference (MD) in serum PAI-1 levels indicated in ng/mL was the major summary result.  The inclusion criteria were met by 33 studies including 10,840 participants, which were then systematically reviewed. The meta-analyses comprised 11 studies.

Result

The MD of PAI-1 levels in NAFLD patients were significantly higher than in controls [17.147 (95% confidence interval (CI): 7.720-26.574)]. Subgroup assessment comparing PAI-1 levels in biopsy-proven NAFLD vs. controls revealed significant results [24.086 (95% CI: 3.812-44.361)]. Profound results were also reported in CT-diagnosed NAFLD [15.523 (95% CI: 7.163-23.883)].

However, there was no significant difference in PAI-1 levels between ultrasound-diagnosed NAFLD patients and controls [10.394 (95% CI: -13.335-34.123)]. PAI-1 levels in NASH patients and controls were not significantly different [26.835 (95% CI: -0.879-54.549)].

Conclusion

To sum up, increased serum PAI-1 levels are linked to adult NAFLD. However, no substantial change was seen in ultrasound-diagnosed NAFLD and NASH people.

Source:

Journal of Gastrointestinal and Liver Diseases

Article:

Plasminogen Activator Inhibitor-1 Levels in Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Authors:

Hasan Alsharoh et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: